Oral Formulation of Angiotensin-(1–7) Improves Lipid Metabolism and Prevents High-Fat Diet–Induced Hepatic Steatosis and Inflammation in Mice
Document Type
Article
Publication Date
2013
Recommended Citation
Feltenberger, J. D., Andrade, J. M., Paraíso, A., Barros, L. O., Filho, A. B., Sinisterra, R. D., . . . Qureshi, M. (2013). Oral formulation of angiotensin-(1-7) improves lipid metabolism and prevents high-fat diet-induced hepatic steatosis and inflammation in mice. Hypertension, 62(2), 324-330.
Publisher's Statement
The original material can be found here: DOI:10.1161/HYPERTENSIONAHA.111.00919
Comments
See original material for full list of authors.